A 2'-modified uridine analog, 2'-O-(methylthiomethoxy)methyl uridine, for siRNA applications

Bioorg Med Chem Lett. 2022 Oct 15:74:128939. doi: 10.1016/j.bmcl.2022.128939. Epub 2022 Aug 12.

Abstract

The medicinal applications of siRNAs have been intensively examined but are still hindered by their low molecular stability under biological conditions and off-target effects, etc. The introduction of chemical modifications to the nucleoside is a promising strategy for solving these limitations. Herein, we describe the development of a new uridine analog, U*, that has a (methylthiomethoxy)methoxy group at the 2' position. The phosphoramidite reagent corresponding to U* was easily synthesized and the RNA oligonucleotides containing U* were stably prepared using a standard protocol for oligonucleotide synthesis. The introduction of U* into the siRNA resulted in positive or negative effects on the targeted gene silencing in a position-dependent manner, and the positive effects were attributed to the improved stability under biological conditions. The thermodynamic analysis of the U*-modified RNAs revealed a slight destabilization of the dsRNA, based depending on which U was strategically utilized to restrain the off-target effects of the siRNA. This study describes a rare example of nucleoside analogs with a large substitution at the 2'-position in the context of an siRNA application and is informative for the development of other analogs to further improve the molecular properties of siRNAs for medicinal applications.

Keywords: Chemical modification; Modified nucleoside; Off-target effect; Stability; siRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Silencing*
  • Nucleosides
  • Oligonucleotides* / chemistry
  • RNA, Small Interfering / chemistry
  • Thermodynamics
  • Uridine / chemistry

Substances

  • Nucleosides
  • Oligonucleotides
  • RNA, Small Interfering
  • Uridine